This content is in French.
Successive vaccination against tick-borne encephalitis and yellow fever
29 février 2024
The 17D yellow fever vaccine is highly effective, but it is frequently injected into people with pre-existing cross-immunity, which can affect its immunogenicity. In this study, researchers assessed the impact of pre-existing…
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Antonio Santos-Peral et al. Prior flavivirus immunity skews the yellow fever vaccine response to cross-reactive antibodies with potential to enhance dengue virus infection. Nat Commun. 2024 Feb 24;15(1):1696.
View the source
